Quantcast
 
New ETF Book by Larry Connors - Click here to read more


 

Desire for Youthful Appearance Will Drive the North American Laser-Assisted Liposuction Device Market Through 2013, According to Millennium Research Group

Thu. September 03, 2009; Posted: 08:07 AM
Stocks RSS
WALTHAM, Mass., Sept 03, 2009 /PRNewswire via COMTEX/ -- PMTI | Quote | Chart | News | PowerRating -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the growing consumer desire for both a youthful appearance and minimally invasive procedures will fuel the North American laser-assisted liposuction device market. MRG's North American Markets for Body Contouring Devices 2009 report finds that over the next five years, many competitors will enter the liposuction device market to capitalize on revenue potential and gain market share.

Available in North America since November 2006, laser-assisted liposuction uses thermal and photodisruptive action to reduce small deposits of fat. In 2008, several laser-assisted liposuction devices were granted Food and Drug Administration (FDA) approval, including CoolTouch's CoolLipo, Cynosure's Smartlipo MPX, Eleme Medical's SmoothLipo, Palomar Medical Technologies' SlimLipo, Sciton's ProLipo PLUS, and Syneron's LipoLite. In Canada, only Cynosure's Smartlipo MPX was approved, however, making it the second such device available for sale in the country. Nevertheless, other competitors are anticipated to enter the Canadian market through 2013; Palomar Medical Technologies' SlimLipo, for example, received Health Canada approval in January 2009.

"In the coming years, the laser-assisted liposuction market will continue to grow robustly and remain the most lucrative fat reduction capital equipment market in North America," says Kevin Flewwelling, Manager of the Aesthetics division at MRG. "Market growth will be accompanied by an expansion in the number of competitors and continuous product innovation, with firms attempting to differentiate their products to gain share."

MRG's North American Markets for Body Contouring Devices 2009 report covers the markets for cellulite reduction, skin tightening, fat reduction, and gastric bands in the US and Canada. The report provides full breakdowns of body contouring procedures by type and device unit sales by subtype, including five-year forecasts, up-to-date market shares, and in-depth qualitative insights. Additionally, physician opinions regarding fat reduction devices, purchasing patterns, and competitors within the US market for fat reduction devices are presented within the report. This information was gathered by MRG in October 2008 at the American Society of Plastic Surgeons conference in Chicago, Illinois.

About Millennium Research Group

Millennium Research Group (www.MRG.net), a Decision Resources, Inc. company (www.DecisionResourcesInc.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the health care sector. The company provides specialized industry expertise through multiclient market research, ongoing Marketrack(TM) projects, customer loyalty tracking, facility-level procedure forecasting, and customized solutions.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the health care industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

    For more information, contact:

    Amy Krohn
    Millennium Research Group
    416-364-7776 x101
    akrohn@mrg.net

    Elizabeth Marshall
    Decision Resources Inc.
    781-296-2563
    emarshall@dresources.com

SOURCE Millennium Research Group

http://www.MRG.net
For full details on Palomar Medical Tech (PMTI) click here. Palomar Medical Tech (PMTI) has Short Term PowerRatings of 8. Details on Palomar Medical Tech (PMTI) Short Term PowerRatings is available at This Link.

    


More News:   Market Updates | Stock Alerts | All Trading News | Stock Index

Email
Print
Archives
Feedback
Email Article Link
Close X
Recipients email address
Your name
Your email
Add a note (optional)




Stocks RSS





Related News [PMTI]
  UPCOMING EVENTS
Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.
* Attendance is strictly limited and are filled on a first-come, first-served basis.
PREMIER SPONSORED LINKS
TRADE CENTER
 
The TradingMarkets Directory
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback

Disclaimer:

The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302

© Copyright 2009 The Connors Group, Inc.


All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2009 The Connors Group, Inc.